CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Abroad (travel likely)RecruitingPHASE2

Conditions

Lymphoblastic Leukemia · Lymphoblastic Leukemia in Children · Lymphoblastic Leukemia, Acute Adult · B-cell Acute Lymphoblastic Leukemia · Large B-cell Lymphoma · CAR

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Singapore General Hospital, Singapore, Singapore
Contact: Study coordinator (Aloysius Ho, MD)
Contact: Principal Investigator (Aloysius Ho)
KK Women's and Children's Hospital, Singapore, Singapore
Contact: Study coordinator (Shui Yen Soh) · soh.shui.yen@singhealth.com.sg · +65 6394 1045
Contact: Principal Investigator (Shui Yen Soh)

Study leads

Shui Yen Soh, MD
Principal Investigator
KK Women's and Children's Hospital
Aloysius Ho, MD
Principal Investigator
Singapore General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Ghent, Belgium · Paris, France

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seattle, United States

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Hematologic Malignancy · Acute Leukemia · Remission

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States